Catalent (CTLT)
(Delayed Data from NYSE)
$55.92 USD
+0.12 (0.22%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $55.90 -0.02 (-0.04%) 7:58 PM ET
5-Strong Sell of 5 5
D Value C Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CTLT 55.92 +0.12(0.22%)
Will CTLT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CTLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CTLT
TAK or CTLT: Which Is the Better Value Stock Right Now?
Charles River (CRL) Forges Collaboration With Ship of Theseus
CTLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Catalent (CTLT) Q2 Earnings Lag Estimates, Gross Margin Down
Other News for CTLT
Goldman’s debt issuers stocks basket
Laughing Water Capital Q1 2024 Letter
Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS)
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
Healthcare M&A Volume Falls in Q1:24, According to Acquisition Data from LevinPro HC